Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...

Precision medicine in endometrial cancer emphasizes molecular drivers, challenging traditional histopathologic approaches and ...

In this exclusive interview with Daily Trust, the president of the Nigerian Cancer Society, Abidemi Omonisi, offers an assessment of cancer situation in the country. He discusses government ...

Novel Quality Controls to Enable QC & Inter-Laboratory Standardization MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of Paige Predict, a suite of cutting-edge digital pathology ...

The key alterations sought are FGFR3 activating mutations or fusions/rearrangements (“susceptible” alterations), for potential use of the FGFR inhibitor erdafitinib (Balversa), and HER2 IHC expression ...

The fear that a biopsy can spread cancer continues to delay diagnosis and treatment. Oncologists explain why biopsy is safe, ...

CHICAGO - Tempus AI, Inc. (NASDAQ:TEM) announced on Wednesday the launch of Paige Predict, a digital pathology solution that analyzes hematoxylin and eosin (H&E) whole slide images to predict ...

Novel Quality Controls to Enable QC & Inter-Laboratory Standardization MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix), a life sciences ...

Daiichi Sankyo and AstraZeneca's Enhertu has been cleared for previously-untreated HER2-positive breast cancer in the US, becoming the first new first-line option in more than a decade. The FDA ...

Opportunities in the Global Refractory Follicular Lymphoma Diagnostics Market include the growing need for MRD monitoring and ...

Opportunities in the Global Diagnostic Specialty Antibodies Market include the rising demand driven by the increasing ...